Huperzine for Cognitive and Functional Impairment in Schizophrenia

Conditions

Schizophrenia

What is the purpose of this trial?

Huperzine is a natural plant product with procognitive properties in patients with Alzheimer's disease. Cognitive difficulties hamper functioning in schizophrenia as well. The present study will investigate whether huperzine improves cognition and functioning in patients with schizophrenia.



Participation Guidelines

Age:
18 Years - 55 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Biomedisyn Corporation
Yale University
Dates:
March 2010
Last Updated:
February 28, 2013
Study HIC#:
0707002913

Clinicaltrials.gov ID: NCT00963846